Although NDDs have been studied for many years, its pathogenesis is still not fully elucidated due to the complexity of pathogenic factors
Skip to main content NOCTEM RESEARCH Protocols Shop All Bundles Research Supplies About Affiliate EN Home
Voss P, Siems W
PGN-EDO51, an enhanced delivery oligonucleotide (EDO) for the treatment of duchenne muscular dystrophy (DMD): results of a phase 1 study in healthy volunteers (P3-8.004)
J Med Internet Res 23(1):e20491 Hernndez-Saavedra D, Hinkley JM, Baer LA, Pinckard KM, Vidal P, Nirengi S, Brennan AM, Chen EY, Narain NR, Bussberg V, Tolstikov VV (2024) Chronic exercise improves hepatic acylcarnitine handling
Material and methods Cell culture HeLa (ATCC Number: CCL-2) and SHSY-5Y (ATCC Number: CRL-2266) cells, STR profiled and free from any contamination, were sourced from National Center for Cell Science repository